Agilent Technologies’ Electronic Measurement Group’s revenues registered a decline of 5 per cent, from $ 855 million in the fourth quarter of 2011 to $ 816 million for the corresponding period in 2012.
The company’s revenues for the period under consideration declined across all key markets with the exception of the computer and semiconductor markets. Its operating margins stood at 23 per cent. Against a net income of $289 million for the fourth quarter in 2011, the company has reported a net income of $425 million in same period for the financial year 2012.
For the full financial year, the company’s income increased from $6.61 billion in 2011 to $6.85 billion in 2012. For the same period, Agilent Technologies net income also increased from $1.012 billion in 2011 to $1.153 billion.
For the fourth quarter, the company had intangible amortisation of $52 million, acquisition, integration and transformation costs of $40 million; and a donation to the Agilent Technologies Foundation of $10 million.
Chemical Analysis revenues declined by 3 per cent compared to a year ago. Environmental and chemical markets also declined, offset by growth in the food and forensics markets. The company’s operating margins stood at 25 per cent.
The company’s life sciences revenues were flat for the year. The growth in the pharmaceutical and environmental markets was offset by a decline in academia and government markets. The vertical’s operating margins stood at 18 per cent.
Diagnostics and Genomics, which includes the Dako acquisition by the company, reported revenues of $156 million with operating margins of 17 per cent.
The company’s revenue for the first quarter of 2013 is expected to be in the range of $1.68 billion to $1.70 billion. And for the full financial year 2013, the company expects revenue of $7.0 billion to $7.20 billion.
